Fermish Clinical Technologies Pvt Ltd is a Contract Research Organization in India providing variety of services for clinical trials in India. It was incorporated on 19th January 2005 and started its operations from October 2006 onwards in New Delhi, India.
Fermish is a super specialty clinical research organization focused in the field of clinical research and healthcare in India and other parts of globe.
Fermish offers the following services for Clinical Research and Pharmaceutical Companies in India and overseas:
Clinical Trial Material Logistics Management Services
Regulatory Affairs in Pharmaceuticals and Clinical Research
IVRS Based Services in Clinical Research
Clinical Research Contract Management
IT Services in Clinical Research
E- Learning the area of Clinical Research
People Behind Fermish
Fermish is managed by Mr Khalid Khan (Chairman- cum- Managing Director), who is a renowned pharmaceutical consultant, and under his expertise, Fermish has taken huge strides towards reaching optimum levels of professional and qualitative service.
Moreover, Mr. Khan is one of the leading regulatory consultants for the Pharmaceutical industry in India and by qualification he is a post graduate pharmacologist from University of New Delhi. Over the last seventeen years he has been actively involved in championing drug development in India through his interactions with the office of Drug Controller General (India). Mr. Khan's primary occupation has been working with pharmaceutical companies to ensure the successful completion of regulatory submissions and help gain regulatory approval. His other areas of expertise and experience are technology transfer, licensing, formulation development and clinical research. Beginning with the initial drug development conception, Mr. Khan plays a vital role in the entire process of drug development and approval in India.
The meaning of Fermish in Hebrew language is 'to mix up and collaborate'. We at Fermish believe in the philosophy of working with our client as their partner in order to achieve the objectives with highest international standards and ethics.
The company envisions becoming a focused super specialty Contract Research Organization in India, and working on new therapy and therapeutic challenges in collaboration with leading pharmaceutical, biotechnology companies and Clinical Research Organizations in India and other parts of the world.